RNA splicing modulator for Huntington’s disease treatment induces peripheral neuropathy

Summary: RNA splicing modulators, a new class of small molecules with the potential to modify the protein expression levels, have quickly been translated into clinical trials. These compounds hold promise for treating neurodegenerative disorders, including branaplam for lowering huntingtin levels in...

Full description

Saved in:
Bibliographic Details
Main Authors: Florian Krach, Tom Boerstler, Stephanie Neubert, Laura Krumm, Martin Regensburger, Jürgen Winkler, Beate Winner
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004225006418
Tags: Add Tag
No Tags, Be the first to tag this record!